EGFR-TKI With/Without Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism

Conditions

• Nonsmall Cell Lung Cancer
• EGFR Gene Mutation

Interventions

• DRUG: EGFR-TK Inhibitor
• DRUG: EGFR-TKI
• DRUG: EGFR-TKI and Chemotherapy

Sponsor

Shanghai Pulmonary Hospital, Shanghai, China